Domesco Medical Import-Export JSC Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

5,19,590.35

5,59,003.99

5,28,896.14

5,10,288.06

4,69,129.22

5,70,508.24

4,48,076.66

Other Operating Income

0.00

Total Operating income

5,19,590.35

5,59,003.99

5,28,896.14

5,10,288.06

4,69,129.22

5,70,508.24

4,48,076.66

Raw Material Cost

4,19,434.74

4,03,718.06

4,56,485.77

4,25,154.98

3,73,041.05

4,30,102.55

3,75,170.65

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

41,903.72

41,445.75

41,251.63

40,328.23

40,577.88

0.00

38,279.46

Power Cost

0.00

Manufacturing Expenses

0.00

993.51

0.00

0.14

0.00

Selling and Distribution Expenses

41,977.82

49,876.07

45,489.89

44,274.61

48,667.76

46,772.52

45,188.46

Other Expenses

-4,190.37

-4,243.93

-4,125.16

-4,032.82

-4,057.80

0.00

-3,827.95

Total Expenditure (Excl Depreciation)

4,61,412.57

4,53,594.13

5,01,975.66

4,69,429.59

4,21,708.81

4,76,875.07

4,20,359.11

Operating Profit (PBDIT) excl Other Income

58177.799999999996

105409.9

26920.5

40858.5

47420.4

93633.2

27717.600000000002

Other Income

7,983.10

9,895.53

7,988.41

-1,188.92

11,384.51

2,482.41

13,274.78

Operating Profit (PBDIT)

71,501.24

1,20,288.83

39,831.11

44,449.30

63,480.58

1,00,559.75

45,346.15

Interest

0.00

993.51

0.00

0.14

0.00

Exceptional Items

0.00

Gross Profit (PBDT)

1,00,155.60

1,55,285.93

72,410.38

85,133.08

96,088.17

1,40,405.70

72,906.01

Depreciation

5,340.36

4,983.43

4,922.21

4,779.75

4,675.66

4,444.16

4,353.83

Profit Before Tax

66,160.88

1,14,311.88

34,908.90

39,669.55

58,804.78

96,115.59

40,992.33

Tax

13,232.18

22,934.34

6,996.68

7,956.60

11,775.70

19,236.25

8,211.48

Provisions and contingencies

0.00

Profit After Tax

44,989.40

91,377.55

23,725.38

26,956.00

39,974.72

65,347.12

13,907.07

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

44,989.40

91,377.55

23,725.38

26,956.00

39,974.72

65,347.12

13,907.07

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

44,989.40

91,377.55

23,725.38

26,956.00

39,974.72

65,347.12

13,907.07

Equity Capital

0.00

Face Value

10000.0

Reserves

17,41,169.67

16,88,240.97

15,96,497.48

15,68,585.26

16,59,596.98

16,12,567.90

15,35,686.42

Earnings per share (EPS)

1295.5

2631.28

683.19

776.22

1151.1

1881.71

400.46

Diluted Earnings per share

1295.5

2631.28

683.19

776.22

1151.1

1881.71

400.46

Operating Profit Margin (Excl OI)

11.2%

18.86%

5.09%

8.01%

10.11%

16.41%

6.19%

Gross Profit Margin

13.76%

21.34%

7.53%

8.71%

13.53%

17.63%

10.12%

PAT Margin

8.66%

16.35%

4.49%

5.28%

8.52%

11.45%

3.1%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 10.76% vs 11.92% in Mar 2025

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 12.54% vs 14.82% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 21.92% vs 7.84% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Domesco Medical Import-Export JSC With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(VND)

Change(%)

Net Sales

5,19,590.35

4,48,086.94

71,503.41

15.96%

Other Operating Income

0.00

Total Operating income

5,19,590.35

4,48,086.94

71,503.41

15.96%

Raw Material Cost

4,19,434.74

2,45,544.39

1,73,890.35

70.82%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

41,903.72

93,014.67

-51,110.95

-54.95%

Power Cost

0.00

Manufacturing Expenses

0.00

840.20

-840.20

-100.00%

Selling and Distribution Expenses

41,977.82

1,20,856.33

-78,878.51

-65.27%

Other Expenses

-4,190.37

-9,385.49

5,195.12

55.35%

Total Expenditure (Excl Depreciation)

4,61,412.57

3,66,400.72

95,011.85

25.93%

Operating Profit (PBDIT) excl Other Income

58,177.78

81,686.22

-23,508.44

-28.78%

Other Income

7,983.10

14,238.83

-6,255.73

-43.93%

Operating Profit (PBDIT)

71,501.24

1,05,634.68

-34,133.44

-32.31%

Interest

0.00

840.20

-840.20

-100.00%

Exceptional Items

0.00

Gross Profit (PBDT)

1,00,155.60

2,02,542.55

-1,02,386.95

-50.55%

Depreciation

5,340.36

9,709.63

-4,369.27

-45.00%

Profit Before Tax

66,160.88

95,084.85

-28,923.97

-30.42%

Tax

13,232.18

14,787.10

-1,554.92

-10.52%

Provisions and contingencies

0.00

Profit After Tax

44,989.40

80,297.76

-35,308.36

-43.97%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

44,989.40

80,297.76

-35,308.36

-43.97%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

44,989.40

80,297.76

-35,308.36

-43.97%

Equity Capital

0.00

Face Value

10,000.00

0.00

Reserves

17,41,169.67

18,16,804.06

-75,634.39

-4.16%

Earnings per share (EPS)

1,295.50

849.45

446.05

52.51%

Diluted Earnings per share

1,295.50

849.45

446.05

52.51%

Operating Profit Margin (Excl OI)

11.20%

18.23%

0.00

-7.03%

Gross Profit Margin

13.76%

23.39%

0.00

-9.63%

PAT Margin

8.66%

17.92%

0.00

-9.26%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 51,959.03 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -7.05% vs 5.69% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 10.76% vs 11.92% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 4,498.94 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -50.77% vs 285.15% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 12.54% vs 14.82% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 6,351.81 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -42.46% vs 246.68% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 21.92% vs 7.84% in Mar 2025

Quarterly - Interest

No Interest in the last few periods

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 11.20%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025